Wodehouse Capital was the sole financial advisor to SGK Labs in this transaction.

AbGel is a recognized brand in the gelatin sponge category and has been used in India since 1980. It is a market leader in this category and used in various surgical applications.  Headquartered in Mumbai with a state-of-the-art manufacturing facility, SGK Labs is renowned for its quality and has been a preferred partner for leading hospitals and medical professionals across India. Healthium aims to further expand the market access of this brand using its wide network of hospitals across India.

Healthium, with a lineage of over 35 years is completely owned by British private equity firm Apax Partners LLP, that has assets in excess of US$ 50 billion. Healthium’s product portfolio includes surgical sutures, needles, a patented arthroscopy portfolio, a urology portfolio, hernia meshes, haemostats, gloves, ligation clips, surgical staplers and other wound closure devices. It holds or has applied for 60 patents in India and U.S.

Complementary business models and strategic product fit for “AbGel” brand to provide strong synergies for Healthium Medtech.